Skip to main content
SpringerLink
Log in
Book cover

Modern Clinical Molecular Techniques pp 23–47Cite as

Test Validation

  • Chapter
  • First Online:

Abstract

Assay validation/verification is a central activity of all clinical laboratories but commands particular emphasis in molecular pathology because of the recent growth and evolution of this discipline within the clinical laboratory and the rapid expansion of the application of molecular testing to patient care and management. Moreover, this area of laboratory medicine relies heavily on the development of in-house methods, which demand additional thoroughness and experimental rigor in their design and evaluation. The intent of this chapter is to provide an overview of the federal requirements that govern laboratory testing validation and verification and to provide general guidance for laboratory directors and technologists in planning a comprehensive step-by-step validation/verification procedure. However, because of the novel nature of molecular diagnostics, its diverse technologies and applications, and the variations found in regulations/guidelines from accrediting agencies, no single protocol can adequately address the full validation/verification process for each molecular test. Therefore, this chapter must be considered only as a general guide for those wishing to evaluate the performance characteristics of a new molecular test or testing platform in the clinical laboratory.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Food and Drug Administration, Department of Health and Human Services. 21 CFR 809. Food and Drugs, Chapter I, Subchapter H, Medical Devices, In Vitro Diagnostic Products for Human Use. Final rule. [41 FR 6903, Feb. 13, 1976]

    Google Scholar 

  2. Health Care Financing Administration (now Centers for Medicare & Medicaid Services), Public Health Service. 42 CFR Parts 405, 410, 416–418, 440, 482–485, 488, 491, 493, and 494. Medicare, Medicaid, and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Final rule with comment period; 1992:7002–243.

    Google Scholar 

  3. Centers for Medicare & Medicaid Services, Centers for Disease Control and Prevention. 42 CFR Part 493. Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule; 2003:3640–714.

    Google Scholar 

  4. Draft Guidance for Industry and FDA Staff. Commercially distributed in vitro diagnostic products labeled for research use only or investigational use only: frequently asked questions. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Biologics Evaluation and Research [Issued 1 June 2011] www.fda.gov/downloads/medicaldevices/deviceregulationandguidancedocuments/ucm071269.pdf. Accessed 27th Aug 2011.

  5. Scott M, Nguyen D. Clinical laboratory compliance: something old something new. LabMedicine. 2009;40:428–35.

    Google Scholar 

  6. Code of Federal Regulations. Title 21. Food and Drugs, vol. 8, chapter 1. Food and Drug Administration, Department of Health and Human Services, part 812. Investigational device exemptions. Washington, DC: U.S. Government Printing Office; 2010.

    Google Scholar 

  7. Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. Jul 2010;23(3):550–76.

    Article  PubMed  CAS  Google Scholar 

  8. Jennings L, Van Deerlin VM, Gulley ML. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. May 2009;133(5):743–55.

    PubMed  Google Scholar 

  9. Cook JD. Chapter 17: Method evaluation. In: Christenson RH, Gregor LC, Johnson LJ, editors. Appleton and Lange’s outline review: clinical chemistry. London: McGraw-Hill Medical Publishing Division; 2001.

    Google Scholar 

  10. Rennert H, Leonard DGB. Chapter 49: Molecular pathology laboratory management. In: Leonard DGB, editor. Molecular pathology in clinical practice. New York/Berlin: Springer; 2007.

    Google Scholar 

  11. Wiktor AE, Van Dyke DL, Stupca PJ, et al. Preclinical validation of fluorescence in situ hybridization assay for clinical practice. Genet Med. 2006;8(1):16–23.

    Article  PubMed  CAS  Google Scholar 

  12. Mattocks CJ, Morris MA, Matthijs G, et al. A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet. Dec 2010;18(12):1276–88.

    Article  PubMed  Google Scholar 

  13. Institute. CaLS. Quantitative molecular methods for infectious diseases; Approved guideline, 2nd edn. Wayne: Clinical and Laboratory Standards Institute; 2010.

    Google Scholar 

  14. Johnson R. Assessment of bias with emphasis on method comparison. Clin Biochem Rev. Aug 2008;29 Suppl 1:S37–42.

    PubMed  Google Scholar 

  15. Nichols JH. Verification of method performance for clinical laboratories. Adv Clin Chem. 2009;47:121–37.

    Article  PubMed  CAS  Google Scholar 

  16. Persing DH. Molecular microbiology: diagnostic principles and practice. 2nd ed. Washington, DC: ASM Press; 2011.

    Google Scholar 

  17. Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. In: Sharp SE, editor. Cumitech 31A, verification and validation of procedures in the clinical microbiology laboratory coordinating. Washington, DC: ASM Press; 2009.

    Google Scholar 

  18. Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. St. Louis: Saunders; 2006.

    Google Scholar 

  19. CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions; Approved guideline, 3rd edn. CLSI document C24-A3. Wayne: Clinical and Laboratory Standards Institute; 2006.

    Google Scholar 

  20. CLSI. Method comparison and bias estimation using patient samples. Approved guidelines, 2nd edn, interim revision. CLSI document EP09-A2-IR. Wayne: Clinical and Laboratory Standards Institute; 2010.

    Google Scholar 

  21. CLSI. Preliminary evaluation of quantitative clinical laboratory methods. Approved guidelines, 3rd edn. CLSI document EP10-A3. Wayne: Clinical and Laboratory Standards Institute; 2006.

    Google Scholar 

  22. CLSI. User verification of performance for precision and trueness. Approved guidelines, 2nd edn. CLSI document EP15-A2. Wayne: Clinical and Laboratory Standards Institute; 2006.

    Google Scholar 

  23. NCCLS. Estimation of total analytical error for clinical laboratory methods. Approved guidelines. NCCLS document EP21-A. Wayne: Clinical and Laboratory Standards Institute; 2003.

    Google Scholar 

  24. NCCLS. Protocols for determination of limits of detection and limits of quantitation. Approved guideline, 2nd edn. NCCLS document EP17-A. Wayne: Clinical and Laboratory Standards Institute; 2004.

    Google Scholar 

  25. CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions. Approved guideline. CLSI document C24-A3. Wayne: Clinical and Laboratory Standards Institute; 2006.

    Google Scholar 

  26. CLSI. Collection, transport, preparation, and storage of specimens for molecular methods. Approved guideline. CLSI document MM13-A. Wayne: Clinical and Laboratory Standards Institute; 2006.

    Google Scholar 

  27. Winn-Deen ES. Standards and controls for genetic testing. Cancer Biomark. 2005;1(4–5):217–20.

    PubMed  CAS  Google Scholar 

  28. Linnet K. Necessary samples size for method comparison studies based on regression analysis. Clin Chem. 1999;45(6):882–94.

    PubMed  CAS  Google Scholar 

  29. CLSI. Analysis of body fluids in clinical chemistry. Approved guideline. CLSI document C49-A. Wayne: Clinical and Laboratory Standards Institute; 2007.

    Google Scholar 

  30. College of American Pathologists. Commission on Laboratory Accreditation, Laboratory Accreditation Program, Microbiology checklist. 07 Nov 2011.

    Google Scholar 

  31. College of American Pathologists. Commission on Laboratory Accreditation, Laboratory Accreditation Program, Molecular Pathology Checklist. 07 Nov 2011.

    Google Scholar 

  32. CLSI. Quantitative molecular methods for infectious diseases. Approved guidelines, 2nd edn. CLSI document MM06-A2. Wayne: Clinical and Laboratory Standards Institute; 2010.

    Google Scholar 

  33. CLSI. Defining, establishing, and verifying reference intervals in the Clinical Laboratory. Approved guideline, 3rd end. CLSI document C28-A3. Wayne: Clinical and Laboratory Standards Institute; 2008.

    Google Scholar 

  34. Kalenday R, Lee D, Schulman AH. Java web tools for PCR, in silico PCR, and oligonucleotide assembly and analysis. Genomics. 2011;98(2):137–44.

    Article  Google Scholar 

  35. International Organization for Standardization. Statistics—vocabulary and symbols—Part 1: General statistical terms and terms used in probability. Geneva: International Organization for Standardization; 2006. ISO 3534–1.

    Google Scholar 

  36. NCCLS. Evaluation of precision performance of quantitative measurement methods. Approved guideline, 2nd edn. NCCLS document EP05-A2. Wayne: Clinical and Laboratory Standards Institute; 2004.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Biomedical Sciences Building Rm 451, Oklahoma City, OK, 73104, USA

    Cindy McCloskey M.D.

  2. Clinical Microbiology and Virology Laboratories, OU Medical Center, Oklahoma City, OK, USA

    Cindy McCloskey M.D.

  3. Molecular Pathology Laboratory, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Biomedical Sciences Building Rm 451, Oklahoma City, OK, 73104, USA

    S. Terence Dunn Ph.D.

Authors
  1. Cindy McCloskey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Terence Dunn Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Terence Dunn Ph.D. .

Editor information

Editors and Affiliations

  1. , Molecular Genetic Technology Program, M.D. Anderson Cancer Center, 1515 Holcombe Blvd. Unit 2, Houston, 77030, Texas, USA

    Peter Hu

  2. , Department of Human Genetics, Emory University School of Medicine, 615 Michael St. NE, Suite 315, Atlanta, 30322, Georgia, USA

    Madhuri Hegde

  3. , Molecular Genetic Technology Program, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 2, Houston, 77030, Texas, USA

    Patrick Alan Lennon

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

McCloskey, C., Dunn, S.T. (2012). Test Validation. In: Hu, P., Hegde, M., Lennon, P. (eds) Modern Clinical Molecular Techniques. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2170-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-2170-2_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-2169-6

  • Online ISBN: 978-1-4614-2170-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation